Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205).
about
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II geneIMP dehydrogenase: structure, mechanism, and inhibition.Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration?Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosisIMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNARetinal isoforms of inosine 5'-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteinsTargeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in miceAnti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapyDifferent characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoformsCrystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug designLoukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal CellsNeural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeletonInosine monophosphate dehydrogenase expression and activity are significantly lower in kidney transplant recipients with diabetes mellitus.Investigating the mechanism of disease in the RP10 form of retinitis pigmentosa.Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantationPharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.On the role of IMPDH1 in retinal degeneration.Pharmacogenetic influences on mycophenolate therapy.Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics.Base-functionalized carbocyclic nucleosides: design, synthesis, and mechanism of antiviral activity.IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway.Specific inhibition of type II inosine monophosphate dehydrogenase activity of Tmolt4 T cell human leukaemia cells by 3-methoxy and di-benzohydroxamic acids, maleic hydrazide and malonic acids.Comparison of bax, waf1, and IMP dehydrogenase regulation in response to wild-type p53 expression under normal growth conditions.Conformational changes and stabilization of inosine 5'-monophosphate dehydrogenase associated with ligand binding and inhibition by mycophenolic acid.Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro.Mechanism of action of the antitumor agents 6-benzoyl-3,3-disubstituted-1,5-diazabicyclo[3.1.0]hexane-2,4-diones: potent inhibitors of human type II inosine 5'-monophosphate dehydrogenase.Proteomics reveals changes in hepatic proteins during chicken embryonic development: an alternative model to study human obesity.Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters.IMP/GTP balance modulates cytoophidium assembly and IMPDH activity.
P2860
Q24607219-F7393944-75AD-4284-A02B-870905C15E1CQ24642299-3D71C5BD-7108-4245-B049-E61A9211E191Q24642828-0CD619DF-D729-44F9-8178-32D5C4364735Q24642869-E9846E18-83AD-4B6E-97AE-C22E04BB95A2Q24643480-E973C793-A239-498D-8DD5-A02449EAAFE9Q24647325-D46C34A3-F6F0-40CB-BD3B-028DAAE8AE5AQ24682900-D33C6130-C911-4289-9B0D-A5A5DC37EAACQ26766115-F9930406-D6C6-45E9-9A1A-1568DC89C7BDQ27332315-0E3936E8-8155-4ACF-AB29-8F8EF8D2A8F0Q27617777-DF35BD45-092B-4CCA-8C39-9FA64EDC0F3EQ28553081-24A93C57-E71D-4AF7-87CC-D0FC1BBF25B7Q28834482-79FAD8BE-2759-46A7-91FD-15BBE6602416Q33942729-A5E27874-58C3-43ED-B65B-1374E66DF281Q33961074-21DBE9A7-88D1-48BB-9EA6-8BB19CD832E2Q34175259-B38932B0-5046-4796-99A2-422A6E8954FCQ34442343-85305F8D-3B3D-447F-BFF7-88CD50BA6169Q34568904-88C466FD-E9DD-4C98-9B73-1ADC82B0B667Q36535994-BE8FFC0A-C943-4674-B46E-2DFFE24F3E7FQ36972991-378D45DA-5404-401B-8FCA-9FECDA4657EDQ37710509-7C2176E9-6A7C-4F55-A234-957CC547AA91Q37855856-9733CA71-8894-48CE-A54F-0399862BFCDAQ39319202-971EDDD1-2A98-4778-9645-5379BE417CF1Q39963834-D3B95A0D-DE36-4A01-9B50-70523857CC56Q40412842-75E2F7F9-BEC6-4D23-ACC6-630108EE7828Q40803751-BC61F768-A2AE-4E5F-81CC-D108F0F80968Q41003479-7649E45E-C20A-4BC1-B075-CA4715A70A3FQ42634081-FEC0C386-7B62-4A89-8547-00791D822CE7Q42716282-BEDEA80A-FB0E-4DC6-8927-B8CF5B854E3CQ43773482-3A6CBA5A-62B5-417D-9B13-3C0602AD0602Q47223871-4F9F3EEE-1F02-4B7B-98FD-4A0489325C8AQ48053887-F62107B3-DA05-4D55-93E1-7EEA5ABF1284Q55382907-436DB545-6FA9-4ED4-B036-BA73B9721311
P2860
Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205).
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Tissue-differential expression ...... dehydrogenase (E.C.1.1.1.205).
@ast
Tissue-differential expression ...... dehydrogenase (E.C.1.1.1.205).
@en
Tissue-differential expression of two distinct genes for human IMP dehydrogenase
@nl
type
label
Tissue-differential expression ...... dehydrogenase (E.C.1.1.1.205).
@ast
Tissue-differential expression ...... dehydrogenase (E.C.1.1.1.205).
@en
Tissue-differential expression of two distinct genes for human IMP dehydrogenase
@nl
prefLabel
Tissue-differential expression ...... dehydrogenase (E.C.1.1.1.205).
@ast
Tissue-differential expression ...... dehydrogenase (E.C.1.1.1.205).
@en
Tissue-differential expression of two distinct genes for human IMP dehydrogenase
@nl
P1433
P1476
Tissue-differential expression ...... dehydrogenase (E.C.1.1.1.205).
@en
P2093
P304
P356
10.1016/0024-3205(94)90150-3
P407
P577
1994-01-01T00:00:00Z